|
4093
|
(Z)-4-Hydroxytamoxifen
|
The more active metabolite of Tamoxifen (SERM; Axon 3252) |
€110.00 |
|
4141
|
Acalabrutinib
|
Orally active, irreversible, and highly selective second-generation BTK inhibitor |
Inquire |
|
4140
|
AZD0156
|
Selective and orally active ATM inhibitor |
€90.00 |
|
4139
|
AZD5582 dihydrochloride
|
Apoptosis proteins (IAPs) inhibitor |
Inquire |
|
4028
|
BI-87G3
|
Highly potent covalent NPAS3 heterodimer inhibitor |
€120.00 |
|
4138
|
CUDC-101
|
Potent HDAC, EGFR, and HER2 inhibitor |
Inquire |
|
4137
|
EPZ005687 hydrochloride
|
EZH2 HMTase inhibitor |
Inquire |
|
4127
|
GNE-781
|
Highly potent, selective, and orally bioavailable CBP inhibitor |
€160.00 |
|
4136
|
HA130
|
Autotaxin (ATX) inhibitor |
Inquire |
|
4135
|
I-BET151
|
BET bromodomain inhibitor |
Inquire |
|
4134
|
I-BET762
|
BET bromodomain inhibitor |
Inquire |
|
4133
|
IPI-145
|
PI3K p110α/γ isoform specific inhibitor |
Inquire |
|
4063
|
KIN1148
|
IRF3 agonist; Influenza vaccine adjuvant |
€120.00 |
|
4099
|
Martinostat hydrochloride
|
HDAC inhibitor (1, 2, 3, 6 Selective) |
€120.00 |
|
4124
|
Momelotinib hydrochloride
|
JAK1 and JAK2 inhibitor |
€120.00 |
|
3840
|
Paltusotine
|
Potent, selective, and orally bioavailable SST2 agonist |
€240.00 |
|
4132
|
PBF-509
|
Selective Adenosine 2A receptor antagonist |
Inquire |
|
4085
|
Sisunatovir
|
Orally bioavailable inhibitor of RSV fusion protein |
€130.00 |
|
4084
|
Sotuletinib
|
Potent, selective and brain-penetrant inhibitor of CSF1R |
€120.00 |
|
3806
|
SPAA-52
|
Highly potent, selective, cell permeable and orally bioavailable LMW-PTP inhibitor |
€120.00 |
|
4024
|
Vorasidenib
|
First-in-class, potent, orally active, brain-penetrant dual mIDH1/2 |
€140.00 |